Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Keybanc analyst Sangita Jain initiated coverage on Solv Energy Inc (NASDAQ:MWH) with an Overweight rating and announced a price target of $34. SOLV Energy shares closed at $27.04 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Robert Burns initiated coverage on Aktis Oncology Inc (NASDAQ:AKTS) with a Buy rating and announced a price target of $30. Aktis Oncology shares closed at $18.81 on Friday. See how other analysts view this stock.
- Baird analyst Ben Kallo initiated coverage on Solv Energy Inc (NASDAQ:MWH) with an Outperform rating and announced a price target of $36. SOLV Energy shares closed at $27.04 on Friday. See how other analysts view this stock.
- Citizens analyst Reni Benjamin initiated coverage on Immix Biopharma Inc (NASDAQ:IMMX) with a Market Outperform rating and announced a price target of $23. Immix Biopharma shares closed at $9.29 on Friday. See how other analysts view this stock.
- Morgan Stanley analyst Jorge Kuri initiated coverage on Agi Inc (NYSE:AGBK) with an Overweight rating and announced a price target of $21. AGI shares closed at $10.50 on Friday. See how other analysts view this stock.
Considering buying AKTS stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments